TreeFrog Therapeutics, a French biotech leveraging a unique cell manufacturing technology to advance a pipeline cell therapies with mass-market potential, and Invetech, a global leader in the development and production of automated manufacturing solutions for cell and advanced therapies, today announce a strategic partnership to...

Despite the COVID crisis, TreeFrog Therapeutics has expanded its team in Bordeaux ! In 2020, we have recruited Application Field Scientists, Lab Technicians, Physicists, Stem Cell Biologists, Bioproduction Engineers...

The Analytical Development Manager will be joining our Analytical Development group during its construction phase. In close cooperation with the R&D & Operations teams, she or he will be involved in the definition and set up of the dedicated lab in all its dimensions: team...

TreeFrog Therapeutics today joins the Japanese Society for Regenerative Medicine (JSRM). Already present in Japan with a local Business Development Officer - Etsuko Takanashi - the French company intends to set up a hub demonstrating its C-Stem technology in 2021 in Japan....

Following an international career in the pharma industry (GSK, Sanofi, Oenobiol), Jean-Luc Treillou co-founded microbiome company LNC therapeutics in 2011, eventually raising 16.5M€ as CEO & Chairman. In 2018, he co-founded TreeFrog Therapeutics with Maxime Feyeux & Kevin Alessandri, taking in charge governance and investor...

Today, Andrea Leonoard, Senior Scientist at TreeFrog Therapeutics was in London, UK to speak at the 3D Cell Culture Conference. She gave an invited presentation about the C-Stem™, our 3D technology for stem cell mass-production.    ...